iridoids - CISMeF

Preferred Label : iridoids;

MeSH definition : A type of MONOTERPENES, derived from geraniol. They have the general form of cyclopentanopyran, but in some cases, one of the rings is broken as in the case of secoiridoid. They are different from the similarly named iridals (TRITERPENES).;

MeSH synonym : Iridoid Derivatives; Derivatives, Iridoid; Iridoid;

MeSH hyponym : secoiridoids; iridoid aglycones; Aglycones, Iridoid;

Wikipedia link : https://en.wikipedia.org/wiki/Iridoid;

Is substance : O;

Details

Origin ID

D039823;

UMLS CUI

C1136328;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- iridoid aglycones [MeSH concept]
- iridoids [MeSH concept]
- secoiridoids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2''S)-10-hydroxy-2''-methoxyoleuropein [MeSH Supplementary Concept]
- 1,5-dihydroxy-3,8-epoxyvalechlorine [MeSH Supplementary Concept]
- 1-isopropyloxygenipin [MeSH Supplementary Concept]
- 10-O-trans-sinapoylgeniposide [MeSH Supplementary Concept]
- 10-acetylborreriagenin [MeSH Supplementary Concept]
- 10-deacetyl suspensolide A aglycone [MeSH Supplementary Concept]
- 11-methoxyviburtinal [MeSH Supplementary Concept]
- 15-demethylplumeride [MeSH Supplementary Concept]
- 2''-epifraxamoside [MeSH Supplementary Concept]
- 2''-hydroxyoleuropein [MeSH Supplementary Concept]
- 2,2-dimethyl-6-isopropenyl-2H-pyran [MeSH Supplementary Concept]
- 2,3-dimethyl-6-isopropyl-4H-pyran [MeSH Supplementary Concept]
- 3-methylbutyric acid 7-hydroxy-7-hydroxymethyl-4-(3-methyl-butyryloxymethyl)-6-oxo-1,6,7,7a-tetrahydrocyclopenta(c)pyran-1-yl ester [MeSH Supplementary Concept]
- 4-hydroxy-E-globularinin [MeSH Supplementary Concept]
- 4-hydroxymethylboschnialactone [MeSH Supplementary Concept]
- 5,6-dihydrovaltrate hydrin [MeSH Supplementary Concept]
- 5-hydroxy-5,6-dihydrovaltrate hydrin [MeSH Supplementary Concept]
- 6'-O-E-p-coumaroylgardoside [MeSH Supplementary Concept]
- 6'-O-p-E-coumaroyl-8-epi-loganic acid [MeSH Supplementary Concept]
- 6'-O-p-hydroxybenzoylantirrinoside [MeSH Supplementary Concept]
- 6-O-p-methoxycinnamoyl scandoside methyl ester [MeSH Supplementary Concept]
- 6-O-veratroyl catalpol [MeSH Supplementary Concept]
- 6-acetylantirrinoside [MeSH Supplementary Concept]
- 6-hydroxy-7-methylhexahydrocyclopenta(c)pyran-3-one [MeSH Supplementary Concept]
- 6-oxogenipin [MeSH Supplementary Concept]
- 6alpha-hydroxyadoxoside [MeSH Supplementary Concept]
- 6beta,7beta-epoxy-8-epi-splendoside [MeSH Supplementary Concept]
- 7,10-dideacetyl suspensolide A aglycone [MeSH Supplementary Concept]
- 7-O-acetyl-8-epi-loganic acid [MeSH Supplementary Concept]
- 7-O-trans-cinnamoyl-6beta-hydroxyloganin [MeSH Supplementary Concept]
- 7-deacetyl suspensolide A aglycone [MeSH Supplementary Concept]
- 7-deoxyloganic acid [MeSH Supplementary Concept]
- 8-deoxyshanzhiside [MeSH Supplementary Concept]
- 9-deoxygelsemide [MeSH Supplementary Concept]
- Zhi-Zi-Hou-Pu decoction [MeSH Supplementary Concept]
- acevaltrate [MeSH Supplementary Concept]
- adenosmoside [MeSH Supplementary Concept]
- allamandin [MeSH Supplementary Concept]
- amarogentin [MeSH Supplementary Concept]
- angelone [MeSH Supplementary Concept]
- anthocleistenolide [MeSH Supplementary Concept]
- asperuloide A [MeSH Supplementary Concept]
- asperuloide B [MeSH Supplementary Concept]
- asperuloide C [MeSH Supplementary Concept]
- asystasioside E [MeSH Supplementary Concept]
- baldrinal [MeSH Supplementary Concept]
- barlerin [MeSH Supplementary Concept]
- boschnaloside [MeSH Supplementary Concept]
- buddlejoside B [MeSH Supplementary Concept]
- caiophoraenin [MeSH Supplementary Concept]
- caryoptoside [MeSH Supplementary Concept]
- caudatoside A [MeSH Supplementary Concept]
- chinensisol [MeSH Supplementary Concept]
- citrifoside [MeSH Supplementary Concept]
- cornifin A iridoid [MeSH Supplementary Concept]
- cornifin B iridoid [MeSH Supplementary Concept]
- cornifin C iridoid [MeSH Supplementary Concept]
- demethyl-2''-epifraxamoside [MeSH Supplementary Concept]
- didrovaltrate [MeSH Supplementary Concept]
- diffusoside A [MeSH Supplementary Concept]
- diffusoside B [MeSH Supplementary Concept]
- eucomoside A [MeSH Supplementary Concept]
- eucomoside B [MeSH Supplementary Concept]
- eucomoside C [MeSH Supplementary Concept]
- fagraldehyde [MeSH Supplementary Concept]
- fraxamoside [MeSH Supplementary Concept]
- fraxisecoside [MeSH Supplementary Concept]
- gardaloside [MeSH Supplementary Concept]
- gardenamide A [MeSH Supplementary Concept]
- gardenoside [MeSH Supplementary Concept]
- gelsemiol [MeSH Supplementary Concept]
- genestifolioside [MeSH Supplementary Concept]
- genipin [MeSH Supplementary Concept]
- genipin 1-gentiobioside [MeSH Supplementary Concept]
- genipin blue [MeSH Supplementary Concept]
- geniposide [MeSH Supplementary Concept]
- gentiolactone [MeSH Supplementary Concept]
- grandifloroside 11-methyl ester [MeSH Supplementary Concept]
- homobaldrinal [MeSH Supplementary Concept]
- hydrachoside A [MeSH Supplementary Concept]
- hydrangenoside E [MeSH Supplementary Concept]
- hydroxybenzoylaucubin [MeSH Supplementary Concept]
- hydroxybenzoylmussaenosidic acid [MeSH Supplementary Concept]
- hydroxyframoside B [MeSH Supplementary Concept]
- incarvoid A [MeSH Supplementary Concept]
- incarvoid B [MeSH Supplementary Concept]
- incarvoid C [MeSH Supplementary Concept]
- ipolamiide [MeSH Supplementary Concept]
- iridodial [MeSH Supplementary Concept]
- iridodial beta-monoenol acetate [MeSH Supplementary Concept]
- iridodiol [MeSH Supplementary Concept]
- iridolactone [MeSH Supplementary Concept]
- iridomyrmecin [MeSH Supplementary Concept]
- isoiridomyrmecin [MeSH Supplementary Concept]
- isovanilloylcatalpol [MeSH Supplementary Concept]
- jasminanhydride [MeSH Supplementary Concept]
- jatadoid A [MeSH Supplementary Concept]
- jatamandoid A [MeSH Supplementary Concept]
- jatamanvaltrate N [MeSH Supplementary Concept]
- jatamanvaltrate O [MeSH Supplementary Concept]
- jatamanvaltrate P [MeSH Supplementary Concept]
- jatamanvaltrate Z1 [MeSH Supplementary Concept]
- javanicoside A [MeSH Supplementary Concept]
- kankanol [MeSH Supplementary Concept]
- kurdnestorianoside [MeSH Supplementary Concept]
- lamalbid [MeSH Supplementary Concept]
- lamiridosin A [MeSH Supplementary Concept]
- ligustrohemiacetal A [MeSH Supplementary Concept]
- ligustrohemiacetal B [MeSH Supplementary Concept]
- loganic acid [MeSH Supplementary Concept]
- loganin [MeSH Supplementary Concept]
- longifolide A [MeSH Supplementary Concept]
- longifolide B [MeSH Supplementary Concept]
- lonijaposide A [MeSH Supplementary Concept]
- lonijaposide B [MeSH Supplementary Concept]
- lonijaposide C [MeSH Supplementary Concept]
- methylcatalpol [MeSH Supplementary Concept]
- monotropein [MeSH Supplementary Concept]
- mussaenoside [MeSH Supplementary Concept]
- naran S [MeSH Supplementary Concept]
- nishindasid [MeSH Supplementary Concept]
- nudifloside A [MeSH Supplementary Concept]
- nudifloside D [MeSH Supplementary Concept]
- obtusadoid A [MeSH Supplementary Concept]
- obtusadoid B [MeSH Supplementary Concept]
- oleuropein [MeSH Supplementary Concept]
- oruwacin [MeSH Supplementary Concept]
- owariensisone [MeSH Supplementary Concept]
- pagide [MeSH Supplementary Concept]
- patridoid I [MeSH Supplementary Concept]
- patridoid II [MeSH Supplementary Concept]
- patriheterdoid B [MeSH Supplementary Concept]
- patriheterdoid C [MeSH Supplementary Concept]
- patriscabrin f [MeSH Supplementary Concept]
- pedicularis-lactone [MeSH Supplementary Concept]
- pensteminoside [MeSH Supplementary Concept]
- pinnatoside [MeSH Supplementary Concept]
- piscrosides A [MeSH Supplementary Concept]
- piscrosides B [MeSH Supplementary Concept]
- plantarenaloside [MeSH Supplementary Concept]
- plumerianine [MeSH Supplementary Concept]
- plumericin [MeSH Supplementary Concept]
- prismatomerin [MeSH Supplementary Concept]
- qingrejiedu [MeSH Supplementary Concept]
- reptoside [MeSH Supplementary Concept]
- sambulin [MeSH Supplementary Concept]
- scabrol A [MeSH Supplementary Concept]
- scutelloside [MeSH Supplementary Concept]
- scyphiphin C [MeSH Supplementary Concept]
- scyphiphin D [MeSH Supplementary Concept]
- secologanic acid [MeSH Supplementary Concept]
- semperoside A [MeSH Supplementary Concept]
- sodium 6-O-methyldeacetylasperulosidate [MeSH Supplementary Concept]
- swerpalactone [MeSH Supplementary Concept]
- swerpatic acid [MeSH Supplementary Concept]
- swertianglide [MeSH Supplementary Concept]
- tetraacetylsecologanin [MeSH Supplementary Concept]
- torricellate [MeSH Supplementary Concept]
- valeriotetrate A [MeSH Supplementary Concept]
- valeriotetrate C [MeSH Supplementary Concept]
- valtral A [MeSH Supplementary Concept]
- valtral B [MeSH Supplementary Concept]
- valtral C [MeSH Supplementary Concept]
- valtrate [MeSH Supplementary Concept]
- valtrate hydrin [MeSH Supplementary Concept]
- valtrates (combination) [MeSH Supplementary Concept]
- vanilloylaucubin [MeSH Supplementary Concept]
- verbenabraside A [MeSH Supplementary Concept]
- verbenabraside B [MeSH Supplementary Concept]
- verminoside [MeSH Supplementary Concept]
- volvaltrate B [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients